Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page.
    Difference
    0.1%
    Check dated 2026-03-25T20:18:35.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:47:53.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2; the previous Revision: v3.4.1 and the government funding lapse notice were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:34:08.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center’s operating status, and the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:28:04.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    UI/metadata updates were applied: a glossary display was added, a new 'Last Update Submitted that Met QC Criteria' label appears, and a 'No FEAR Act Data' notice with revision tag v3.4.0. Capitalization tweaks were made and the old v3.3.4 tag was removed.
    Difference
    0.2%
    Check dated 2026-01-28T03:41:15.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    An underlying site revision updated from v3.3.3 to v3.3.4; no study content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:44:54.000Z thumbnail image

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.